These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 12150888)

  • 1. The role of the NKG2D immunoreceptor in immune cell activation and natural killing.
    Jamieson AM; Diefenbach A; McMahon CW; Xiong N; Carlyle JR; Raulet DH
    Immunity; 2002 Jul; 17(1):19-29. PubMed ID: 12150888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costimulation of multiple NK cell activation receptors by NKG2D.
    Ho EL; Carayannopoulos LN; Poursine-Laurent J; Kinder J; Plougastel B; Smith HR; Yokoyama WM
    J Immunol; 2002 Oct; 169(7):3667-75. PubMed ID: 12244159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of V gamma 9V delta 2 T cells by NKG2D.
    Rincon-Orozco B; Kunzmann V; Wrobel P; Kabelitz D; Steinle A; Herrmann T
    J Immunol; 2005 Aug; 175(4):2144-51. PubMed ID: 16081780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo.
    Wiemann K; Mittrücker HW; Feger U; Welte SA; Yokoyama WM; Spies T; Rammensee HG; Steinle A
    J Immunol; 2005 Jul; 175(2):720-9. PubMed ID: 16002667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engagement of NKG2D by cognate ligand or antibody alone is insufficient to mediate costimulation of human and mouse CD8+ T cells.
    Ehrlich LI; Ogasawara K; Hamerman JA; Takaki R; Zingoni A; Allison JP; Lanier LL
    J Immunol; 2005 Feb; 174(4):1922-31. PubMed ID: 15699119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated, but not resting, T cells can be recognized and killed by syngeneic NK cells.
    Rabinovich BA; Li J; Shannon J; Hurren R; Chalupny J; Cosman D; Miller RG
    J Immunol; 2003 Apr; 170(7):3572-6. PubMed ID: 12646619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages.
    Diefenbach A; Jamieson AM; Liu SD; Shastri N; Raulet DH
    Nat Immunol; 2000 Aug; 1(2):119-26. PubMed ID: 11248803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity.
    Diefenbach A; Jensen ER; Jamieson AM; Raulet DH
    Nature; 2001 Sep; 413(6852):165-71. PubMed ID: 11557981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin.
    Pende D; Cantoni C; Rivera P; Vitale M; Castriconi R; Marcenaro S; Nanni M; Biassoni R; Bottino C; Moretta A; Moretta L
    Eur J Immunol; 2001 Apr; 31(4):1076-86. PubMed ID: 11298332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity.
    Diefenbach A; Hsia JK; Hsiung MY; Raulet DH
    Eur J Immunol; 2003 Feb; 33(2):381-91. PubMed ID: 12645935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA.
    Bauer S; Groh V; Wu J; Steinle A; Phillips JH; Lanier LL; Spies T
    Science; 1999 Jul; 285(5428):727-9. PubMed ID: 10426993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human tumor-derived exosomes down-modulate NKG2D expression.
    Clayton A; Mitchell JP; Court J; Linnane S; Mason MD; Tabi Z
    J Immunol; 2008 Jun; 180(11):7249-58. PubMed ID: 18490724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A DNA-based cancer vaccine enhances lymphocyte cross talk by engaging the NKG2D receptor.
    Zhou H; Luo Y; Kaplan CD; Krüger JA; Lee SH; Xiang R; Reisfeld RA
    Blood; 2006 Apr; 107(8):3251-7. PubMed ID: 16368879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-21 down-regulates NKG2D/DAP10 expression on human NK and CD8+ T cells.
    Burgess SJ; Marusina AI; Pathmanathan I; Borrego F; Coligan JE
    J Immunol; 2006 Feb; 176(3):1490-7. PubMed ID: 16424177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-2-activated CD8+CD44high cells express both adaptive and innate immune system receptors and demonstrate specificity for syngeneic tumor cells.
    Dhanji S; Teh HS
    J Immunol; 2003 Oct; 171(7):3442-50. PubMed ID: 14500639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NKG2D ligation without T cell receptor engagement triggers both cytotoxicity and cytokine production in dendritic epidermal T cells.
    Nitahara A; Shimura H; Ito A; Tomiyama K; Ito M; Kawai K
    J Invest Dermatol; 2006 May; 126(5):1052-8. PubMed ID: 16484989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer cell-mediated lysis of dorsal root ganglia neurons via RAE1/NKG2D interactions.
    Backström E; Chambers BJ; Ho EL; Naidenko OV; Mariotti R; Fremont DH; Yokoyama WM; Kristensson K; Ljunggren HG
    Eur J Immunol; 2003 Jan; 33(1):92-100. PubMed ID: 12594837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
    Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
    J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing human NKG2D, DAP10, and DAP12 reduces cytotoxicity of activated CD8+ T cells and NK cells.
    Karimi M; Cao TM; Baker JA; Verneris MR; Soares L; Negrin RS
    J Immunol; 2005 Dec; 175(12):7819-28. PubMed ID: 16339517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NKG2D-mediated cytotoxicity toward oligodendrocytes suggests a mechanism for tissue injury in multiple sclerosis.
    Saikali P; Antel JP; Newcombe J; Chen Z; Freedman M; Blain M; Cayrol R; Prat A; Hall JA; Arbour N
    J Neurosci; 2007 Jan; 27(5):1220-8. PubMed ID: 17267578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.